Want to join the conversation?
The U.S. Food and Drug Administration (FDA) approved $MDT's IN.PACT Admiral drug-coated balloon as a treatment for in-stent restenosis (ISR) in patients with peripheral artery disease. FDA approval was based on ISR data from the IN.PACT Global Study compared to a standard percutaneous balloon angioplasty control.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)